CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial
Stebbing, Justin, Prof, Baranau, Yauheni, MD, Baryash, Valeriy, MD, Manikhas, Alexey, MD, Moiseyenko, Vladimir, Prof, Dzagnidze, Giorgi, MD, Zhavrid, Edvard, Prof, Boliukh, Dmytro, MD, Stroyakovskii, Daniil, MD, Pikiel, Joanna, MD, Eniu, Alexandru, MD, Komov, Dmitry, MD, Morar-Bolba, Gabriela, MD, Li, Rubi K, MD, Rusyn, Andriy, Prof, Lee, Sang Joon, PhD, Lee, Sung Young, MS, Esteva, Francisco J, Prof
Published in The lancet oncology (01.07.2017)
Published in The lancet oncology (01.07.2017)
Get full text
Journal Article